SynthesisFrontiers in oncology2024

Addition of PD-1/PD-L1 inhibitors to chemotherapy for triple-negative breast cancer: a meta-analysis.

Juan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.